Join
Live feed
·
NEWSReleasevia Quantisnow
NightHawk Biosciences Inc. logo

NightHawk's Scorpius BioManufacturing Subsidiary Awarded A Multimillion- Dollar Contract With A Biotech Company To Support Its Phase 2 Clinical Program

ByQuantisnow·Wall Street's wire, on your screen.
NHWK· NightHawk Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NHWK (NightHawk Biosciences Inc.) and more on Quantisnow.

NightHawk's Scorpius BioManufacturing Subsidiary Awarded A Multimillion- Dollar Contract With A Biotech Company To Support Its Phase 2 Clinical Program | Quantisnow